跳至主要内容
临床试验/NCT01845753
NCT01845753已完成不适用

Molecular Screening for Lynch Syndrome in Denmark

Vejle Hospital3 个研究点 分布在 1 个国家目标入组 5,000 人开始时间: 2012年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
5,000
试验地点
3
主要终点
Rate of Lynch Syndrome in a population of primary colorectal cancer

研究概览

简要总结

A clinically applicably strategy for molecular screening for Lynch Syndrome is being implemented in Denmark.

Based on sequential analysis with immunohistochemistry and methylation analysis, patients with possible hereditary colorectal cancer are identified. These patients are offered genetic risk assessment and counselling.

The study hypothesis is that molecular screening will identify more patients with Lynch Syndrome than the family history alone.

Prospective data collection is performed using established clinical databases.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Histological diagnosis of colorectal adenocarcinoma
  • Diagnosed at one of the departments of pathology in Denmark

排除标准

  • 未提供

结局指标

主要结局

Rate of Lynch Syndrome in a population of primary colorectal cancer

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验

Molecular Screening for Lynch Syndrome in Denmark | 临床试验